FEI Reports Fourth Quarter 2015 Results


Record Revenue of $273 Million and EPS of $1.17
Record Bookings of $294 Million and Book-to-Bill of 1.08-to-1

HILLSBORO, Ore., Feb. 02, 2016 (GLOBE NEWSWIRE) -- FEI Company (NASDAQ:FEIC) today reported results for the fourth quarter of 2015.  Fourth quarter revenue of $273 million was up 2.7% compared with $265 million for fourth quarter of 2014.   Movements in foreign exchange rates negatively impacted revenue for the fourth quarter of 2015 by approximately $16 million.  Excluding the impact of foreign exchange movements and $1.7 million of revenue related to acquisitions, fourth quarter organic revenue was up 8.2% compared with the fourth quarter of 2014. 

Diluted earnings per share computed on the basis of accounting principles generally accepted in the United States ("GAAP") were $1.17 for the fourth quarter of 2015, compared with $0.79 in the fourth quarter of 2014.  Net income for the quarter was $48 million compared with $33 million in the fourth quarter of 2014.  

On December 10, 2015, the company completed the acquisition of DCG Systems.  Included in fourth quarter 2015 results is $1.0 million of DCG revenue and a net negative impact to net income of $3.0 million, or $0.07 per share.

The company’s backlog of orders at the end of the fourth quarter of 2015 was $591 million, compared with $536 million at the end of the fourth quarter of 2014 and $562 million at the end of the third quarter of 2015.  Bookings for the fourth quarter of 2015 were a record $294 million, resulting in a book-to-bill ratio of 1.08-to-1.

For the full year 2015, revenue was $930 million compared with $956 million for 2014.  Excluding the impact of $55 million related to negative foreign exchange movements and $4.1 million of revenue related to acquisitions, 2015 organic revenue was up 2.6% compared with 2014.  Bookings were $996 million compared with $1.05 billion for 2014.  Adjusted EBITDA for 2015 was $217 million compared with $199 million for 2014.  A reconciliation of adjusted EBITDA to GAAP operating income is included in a table attached to this press release.  Net income for 2015 was $124 million or $2.96 per diluted share, compared with $105 million or $2.47 per diluted share for 2014. 

Net cash provided by operating activities for the fourth quarter of 2015 was $70 million, unchanged from the fourth quarter of 2014.  During the quarter, the company paid cash dividends of $12 million, invested $6.9 million on plant and equipment and repurchased 443,000 shares of its common stock at an average price of $75.77. 

In 2015, net cash provided by operating activities was $204 million, compared with $143 million in 2014.  For the full year, the company paid cash dividends of $46 million, invested $17 million in plant and equipment and repurchased 1.4 million shares of its common stock at an average price of $76.78.  Total cash, investments and restricted cash at the end of 2015 was $351 million. 

“2015 finished on a positive note with record revenue, operating margin and earnings per share in the fourth quarter,” commented Don Kania, president and CEO. “The strong results in the quarter were driven by our Science segment, with record orders and revenue from life sciences customers.  

“As we look to 2016, we see improved organic revenue growth driving increased earnings and cash flow for FEI.  We are especially excited about the adoption of cyro-EM by life sciences customers and there is opportunity for an improved back half of the year in the semiconductor market as spending picks up at our larger customers.”

Outlook

For full year 2016, the company expects reported revenue to be in the range of $1.02 billion to $1.05 billion.  On an organic basis, excluding revenue from DCG and the expected negative impact of a stronger U.S dollar, revenue is expected to grow in the range of 3.5% to 6.5%, compared with 2015.  Adjusted EBITDA is expected to be in the range of $235 million to $245 million.  GAAP earnings per fully diluted share are expected to be in the range of $3.55 to $3.70.  This range is based on an expected tax rate for the full year of approximately 21%. 

For the first quarter of 2016, the company expects reported revenue to be in the range of $215 million to $225 million.  On an organic basis, excluding revenue from DCG and the expected negative impact of a stronger U.S. dollar, first quarter 2016 revenue is expected to be in the range of flat to down 4.0% compared with the first quarter of 2015.  First quarter GAAP earnings per fully diluted share are expected to be in the range of $0.46 to $0.57. 

Investor Conference Call - 2:00 p.m. Pacific Time, Tuesday, February 2, 2016

Parties interested in listening to FEI's quarterly conference call may do so by dialing 1-877-407-8293 (U.S., toll-free) or +1-201-689-8349 (international and toll), with the conference title:  FEI Fourth Quarter Earnings Conference Call.  The call can also be accessed via the web by going to FEI's Investor Relations page at http://investor.fei.com/event, where the webcast will also be archived.

Safe Harbor Statement

This news release contains forward-looking statements that include guidance for revenue and/or earnings per share for the first quarter of 2016 and full year 2016, the impact of certain items on our results for these periods, statements regarding our sources of revenue, our investments and expenditures, foreign currency exchange rates, assumptions about tax rates, the allocation of our resources and expenditures, expectations for performance from the acquisition of DCG, and developments, trends, and opportunities in certain markets.  Forward-looking statements may also be identified by words and phrases that refer to future expectations, such as "guidance", "guiding", "forecast", "toward", "plan", "expect", "are expected", "is expected", "believe", "anticipate", "will", "projecting", "look forward", “continue to see”, “outlook” and other similar words and phrases. Factors that could affect these forward-looking statements include, but are not limited to:  the global economic environment, particularly continued slower growth in China and emerging markets; lower than expected customer orders, including for recently-introduced products; potential weakness of the Science and Industry market segments, including continued weakness in the oil and gas sector of the Industry segment resulting from lower oil prices; fluctuations in foreign exchange rates, which, among other things, can affect revenues,  margins, bookings, backlog and the competitive pricing of our products; cyclical and other changes and increased volatility in the semiconductor industry, which is a major component of Industry market segment revenue; failure to achieve the anticipated benefits of the DCG acquisition; changes in backlog and the timing of shipments from backlog, which may create forecasting challenges; potential delayed or reduced governmental spending to support expected orders; potential disruption in the company's operations due to organizational changes; the relative mix of higher-margin and lower-margin products; potential for increased volatility and challenges in forecasting resulting from larger sales transactions, cancellations and rescheduling of orders by customers; risks associated with a high percentage of the company's revenue coming from book and ship business, when the order for a product is placed by the customer in the same quarter as the planned shipment, and risks associated with building and shipping a high percentage of the company’s quarterly revenue in the last month of the quarter; delays in meeting all accounting requirements for revenue recognition; the ongoing determination of the effectiveness of foreign exchange hedge transactions; the relative mix of U.S. and non-U.S. sales; additional costs related to future merger and acquisition activity; failure of the company to achieve anticipated benefits of acquisitions and collaborations, including failure to achieve financial goals and integrate acquisitions successfully; reduced profitability due to failure to achieve or sustain margin improvement in service or product manufacturing; potential disruption in manufacturing or unexpected additional costs due to the transition from older to newer products; failure to achieve improved operational efficiency and other benefits from infrastructure investments and restructuring activities; potential additional restructurings, realignments and reorganizations;  inability to deploy products as expected or delays in shipping products due to technical problems or barriers, especially with regard to recently introduced TEM products; bankruptcy or insolvency of customers or suppliers; and changes in U.S. and foreign tax rates and laws, accounting rules regarding taxes or agreements with tax authorities. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.

About FEI:

FEI Company (Nasdaq:FEIC) designs, manufactures and supports a broad range of high-performance microscopy workflow solutions that provide images and answers at the micro-, nano- and picometer scales. Its innovation and leadership enable customers in industry and science to increase productivity and make breakthrough discoveries. Headquartered in Hillsboro, Ore., USA, FEI has over 3,000 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.


FEI Company and Subsidiaries
Consolidated Balance Sheets
(In thousands)
(Unaudited)
 
 December 31,
 2015
 December 31,
 2014
Assets   
Current Assets:   
Cash and cash equivalents$300,911  $300,507 
Short-term investments in marketable securities  61,688 
Short-term restricted cash19,119  15,698 
Receivables, net213,128  227,354 
Inventories, net170,513  176,440 
Deferred tax assets10,566  8,225 
Other current assets33,614  35,503 
Total current assets747,851  825,415 
Long-term investments in marketable securities8,677  85,865 
Long-term restricted cash22,113  38,369 
Property plant and equipment, net155,608  163,794 
Intangible assets, net35,943  54,111 
Goodwill145,607  170,773 
Deferred tax assets6,719  6,605 
Long-term inventories47,109  50,731 
Other assets, net180,222  22,155 
Total Assets$1,349,849  $1,417,818 
Liabilities and Shareholders' Equity   
Current Liabilities:   
Accounts payable$58,708  $78,308 
Accrued payroll liabilities38,643  38,599 
Accrued warranty reserves14,107  13,005 
Deferred revenue101,155  96,924 
Income taxes payable12,124  5,299 
Accrued restructuring and reorganization655  9,161 
Other current liabilities52,630  56,146 
Total current liabilities278,022  297,442 
Long-term deferred revenue44,745  34,021 
Deferred tax liabilities5,187  9,576 
Other liabilities31,819  35,454 
Shareholders' Equity:   
Preferred stock - 500 shares authorized; none issued and outstanding   
Common stock - 70,000 shares authorized; 40,855 and 41,797 shares issued and outstanding, no par value533,062  607,250 
Retained earnings538,053  461,586 
Accumulated other comprehensive loss(81,039) (27,511)
Total shareholders’ equity990,076  1,041,325 
Total Liabilities and Shareholders' Equity$1,349,849  $1,417,818 


FEI Company and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
 
 Thirteen Weeks Ended Fifty-Two Weeks Ended
 December 31,
 2015
 December 31,
 2014
 December 31,
 2015
 December 31,
 2014
Net Sales:       
Products$206,164  $205,207  $685,651  $722,666 
Service66,402  60,098  244,481  233,614 
Total net sales272,566  265,305  930,132  956,280 
Cost of Sales:       
Products101,106  106,718  336,071  369,043 
Service38,522  35,188  139,470  139,082 
Total cost of sales139,628  141,906  475,541  508,125 
Gross profit132,938  123,399  454,591  448,155 
Operating Expenses:       
Research and development25,294  25,434  95,569  102,613 
Selling, general and administrative49,181  49,170  181,563  197,682 
Impairment of goodwill and long-lived assets    26,596   
Restructuring and reorganization2  7,201  (563) 18,459 
Total operating expenses74,477  81,805  303,165  318,754 
Operating Income58,461  41,594  151,426  129,401 
Other Expense, Net(705) (564) (3,634) (2,471)
Income Before Income Taxes57,756  41,030  147,792  126,930 
Income Tax Expense9,509  7,639  23,783  21,866 
Net Income$48,247  $33,391  $124,009  $105,064 
Basic Net Income Per Share$1.18  $0.80  $2.99  $2.50 
Diluted Net Income Per Share$1.17  $0.79  $2.96  $2.47 
Weighted Average Shares Outstanding:       
Basic40,887  41,726  41,419  41,969 
Diluted41,256  42,221  41,839  42,528 


FEI Company and Subsidiaries
Consolidated Statements of Operations
(Unaudited)
 
 Thirteen Weeks Ended (1) Fifty-Two Weeks Ended (1)
 December 31,
 2015
 December 31,
 2014
 December 31,
 2015
 December 31,
 2014
Net Sales:       
Products75.6% 77.3% 73.7% 75.6%
Service24.4  22.7  26.3  24.4 
Total net sales100.0% 100.0% 100.0% 100.0%
Cost of Sales:           
Products37.1% 40.2% 36.1% 38.6%
Service14.1  13.3  15.0  14.5 
Total cost of sales51.2% 53.5% 51.1% 53.1%
Gross Margin:           
Products51.0% 48.0% 51.0% 48.9%
Service42.0  41.4  43.0  40.5 
Gross margin48.8  46.5  48.9  46.9 
Operating Expenses:           
Research and development9.3% 9.6% 10.3% 10.7%
Selling, general and administrative18.0  18.5  19.5  20.7 
Impairment of goodwill and long-lived assets    2.9   
Restructuring and reorganization  2.7  (0.1) 1.9 
Total operating expenses27.3% 30.8% 32.6% 33.3%
Operating Income21.4% 15.7% 16.3% 13.5%
Other Expense, Net(0.3)% (0.2)% (0.4)% (0.3)%
Income Before Income Taxes21.2% 15.5% 15.9% 13.3%
Income Tax Expense3.5% 2.9% 2.6% 2.3%
Net Income17.7% 12.6% 13.3% 11.0%

(1)       Percentages may not add due to rounding.

FEI Company and Subsidiaries
Consolidated Summary of Cash Flows
(In thousands)
(Unaudited)
 
 Thirteen Weeks Ended Fifty-Two Weeks Ended
 December 31,
 2015
 December 31,
 2014
 December 31,
 2015
 December 31,
 2014
Net Income$48,247  $33,391  $124,009  $105,064 
Depreciation6,437  6,663  24,801  29,042 
Amortization2,745  3,812  11,225  14,290 
Stock-based compensation5,764  5,676  22,379  23,132 
Impairment of goodwill and long-lived assets  1,097  26,596  1,379 
Other changes in working capital6,555  19,668  (4,530) (29,998)
Net cash provided by operating activities69,748  70,307  204,480  142,909 
Acquisition of property, plant and equipment(6,914) (14,052) (17,023) (49,481)
Payments for acquisitions, net of cash acquired(161,811)   (167,188) (65,049)
Other investing activities67,518  15,681  144,360  (2,285)
Net cash (used in) provided by investing activities(101,207) 1,629  (39,851) (116,815)
Dividends paid on common stock(12,333) (10,443) (45,673) (31,062)
Repurchases of common stock(34,664) (22,208) (107,238) (62,523)
Other financing activities2,465  (1,757) 11,139  9,183 
Net cash used in financing activities(44,532) (34,408) (141,772) (84,402)
Effect of exchange rate changes(4,956) (9,462) (22,453) (25,355)
(Decrease) increase in cash and cash equivalents(80,947) 28,066  $404  $(83,663)
Cash and Cash Equivalents:       
Beginning of period381,858  272,441  300,507  384,170 
End of period$300,911  $300,507  $300,911  $300,507 
Supplemental Cash Flow Information:       
Cash paid for income taxes, net$2,768  $2,525  $25,190  $16,983 
Accrued purchases of plant and equipment2,193  700  2,193  700 
Dividends declared but not paid12,257  10,385  12,257  10,385 


FEI Company and Subsidiaries
Adjusted EBITDA Reconciliation
(In thousands)
(Unaudited)
 
 Thirteen Weeks Ended Fifty-Two Weeks Ended
 December 31,
 2015
 December 31,
 2014
 December 31,
 2015
 December 31,
 2014
GAAP Operating Income$58,461  $41,594  $151,426  $129,401 
Add: Depreciation6,437  6,663  24,801  29,042 
Add: Amortization2,745  3,812  11,225  14,290 
EBITDA67,643  52,069  187,452  172,733 
Add: Impairment of goodwill and long-lived assets    26,596   
Add: Restructuring and integration costs562  9,760  (3) 26,559 
Add: DCG transaction costs3,257    3,257   
Adjusted EBITDA$71,462  $61,829  $217,302  $199,292 


FEI Company and Subsidiaries
Supplemental Data Table
($ in millions, except per share amounts)
(Unaudited)
 
 Thirteen Weeks Ended Fifty-Two Weeks Ended
 December 31,  December 31, December 31, December 31,
 2015 2014 2015 2014
Income Statement Highlights:       
Consolidated sales$272.6  $265.3  $930.1  $956.3 
Gross margin48.8% 46.5% 48.9% 46.9%
Net income$48.2  $33.4  $124.0  $105.1 
Diluted net income per share$1.17  $0.79  $2.96  $2.47 
                
Sales and Bookings Highlights:               
Sales by Segment               
Industry Group$109.6  $109.5  $446.3  $450.2 
Science Group163.0  155.8  483.8  506.1 
Sales by Geography               
USA & Canada$80.0  $75.9  $297.7  $305.6 
Europe87.0  80.6  246.9  267.8 
Asia-Pacific and Rest of World105.6  108.8  385.5  382.9 
Gross Margin by Segment               
Industry Group51.6% 49.9% 52.2% 51.1%
Science Group46.9  44.1  45.8  43.1 
Bookings and Backlog               
Bookings - Total$294.3  $273.3  $995.6  $1,046.4 
Book-to-bill Ratio1.08  1.03  1.07  1.09 
Backlog - Total$590.6  $535.6  $590.6  $535.6 
Backlog - Service173.5  170.8  173.5  170.8 
Bookings by Segment               
Industry Group$106.2  $102.3  $470.7  $493.4 
Science Group188.1  171.0  524.9  553.0 
Bookings by Geography               
USA & Canada$105.1  $69.0  $348.6  $303.5 
Europe93.2  88.3  259.3  321.8 
Asia-Pacific and Rest of World96.0  116.0  387.6  421.1 
                
Balance Sheet and Other Highlights:               
Cash, equivalents, investments, restricted cash$350.8  $502.1  $350.8  $502.1 
Days sales outstanding (DSO)71  78  71  78 
Days in inventory149  152  149  152 
Days in payables (DPO)38  50  38  50 
Cash Cycle (DSO + Days in Inventory - DPO)182  180  182  180 
Working capital$469.8  $528.0  $469.8  $528.0 
Headcount (permanent and temporary)3,060  2,660  3,060  2,660 
Euro average rate1.10  1.25  1.11  1.33 
Euro ending rate1.09  1.21  1.09  1.21 
Yen average rate121.44  113.50  121.02  105.45 
Yen ending rate120.39  119.59  120.39  119.59 

 


            

Contact Data